Connecting with the larger purpose of our work

Journal of Pharmaceutical Sciences

Volumn 97, Issue 3, 2008, Pages 1041-1046

  Cohen, Gary M ^a  

^a BD Technologies   (United States)

Author keywords

Global health; HIV AIDS; Injectors; Measles; Pediatric; Philanthropy; Pregnancy; Tuberculosis; Vaccine delivery

Indexed keywords

ANTIRETROVIRUS AGENT; POLIOMYELITIS VACCINE; TETANUS TOXOID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOMEDICINE; CD4 LYMPHOCYTE COUNT; CHILD HEALTH; CHILDHOOD MORTALITY; COMPETENCE; COOPERATION; DEVELOPING COUNTRY; EMPLOYEE; EMPLOYEE ATTITUDE; FLOW CYTOMETRY; FUNDING; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; JOB PERFORMANCE; JOB SATISFACTION; LABORATORY; MEDICAL TECHNOLOGY; MONEY; NOTE; ORGANIZATION; PANDEMIC; PUBLIC HEALTH SERVICE; REWARD; STAFF TRAINING; SUSTAINABLE DEVELOPMENT; SYRINGE; TETANUS; TETANUS PROPHYLAXIS; TRAINING; TUBERCULOSIS; VOLUNTEER; WORK; ALTRUISM; ARTICLE; CHILD; FEMALE; HEALTH; HEALTH CARE PLANNING; PREGNANCY; PREVENTIVE HEALTH SERVICE; VOLUNTARY WORKER;

ALTRUISM; CHILD; CHILD MORTALITY; FEMALE; HEALTH PRIORITIES; HIV INFECTIONS; HUMANS; IMMUNIZATION PROGRAMS; PREGNANCY; TUBERCULOSIS; VOLUNTARY WORKERS; WORLD HEALTH;

EID: 42949151074     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21248     Document Type: Note

References (34)

1. Sciarappa T. 2007. Compassion, Commitment Fuel Society on a Mission. Human Resource Mag: 57.
2. Ambrose D. 2006. Making peace with your work. An invitation to find meaning in the madness. Andover, MN: Expert Publishing.
3. Becton Dickinson and Company. 1997. Celebrating the First One Hundred: 1897-1997. Franklin Lakes, NJ: Becton Dickinson and Company.
4. Samet JM. 2005. Conversations with DA Henderson. Epidemiology 16:266-269.
5. Hauri AM, Armstrong GL, Hutin YJF. 2004. The global burden of disease attributable to contaminated injections given in health care settings. Internat J STD AIDS 15:7-16.
6. Kosinski AJ. 1990. Single-use syringe having misuse resistant features. United States Patent and Trademark Office, Patent No. 4961728.
7. WHO-UNICEF-UNFP. 1999. A joint statement on the use of auto-disable syringes in immunization services. Geneva: World Health Organization WHO/V&B/99.2.
8. Data from BD internal records on shipments of auto-disable syringes. Franklin Lakes, NJ.
9. WHO's, 2001 Contribution to the Report for the Follow-up to the World Summit for Children In Preparation for the UN General Assembly Special Session on Children, September 2001.
10. UNICEF. 2002. UNICEF hails global progress towards elimination of maternal and neo-natal tetanus. News Release, New York, April 17.
11. Interview with Dr. Francois Gasse, Senior Health Project Officer, UNICEF Online Magazine, April 2004.
12. Annual Report of the US Fund for UNICEF, New York, 2006, page 11.
13. Wolfson LJ, Stebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW, Hersh BS. The measles initiative. 2007.Has the 2005 measles mortality reduction goal been achieved? A natural modeling study. Lancet 369:191-200.
14. Dec 05 AIDS epidemic update. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2005.
15. World Health Organizaton. 2004. Scaling up anti-retroviral therapy in resource-limited settings: Treatment guidelines for a public health approach 2003 revision. Geneva: World Health Organization.
16. World Health Organization. 2007. Towards Universal Access: scaling up priority HIV/AIDS interventions in the health sector. WHO progress report. Geneva. http://www.who.int/hiv/facts/ Progress%20December%202006%20April%202007%20-press.ppt#340.
17. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. 2006. Laboratory medicine in Africa: A barrier to effective health care. Clin Infect Dis 42:377-382.
18. World Economic Forum, Global Health Initiative. 2006. From funding to action: strengthening healthcare systems in Sub-Saharan Africa. White paper for consultation. Geneva: World Economic Forum, Global Health Initiative. http://www.wef. sum.org/pdf/whitepaper.pdf.
19. World Health Organization, UNAIDS, UNICEF. Toward Universal Access: Scaling up priority HIV/AIDS interventions in the health sector. Progress report, April 2007.
20. http://www.aidsinfonet.org/factsheet_detail.php?fsnumber=124.
21. Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL, Curran JW. 1992. 1993 revised classification system for HIV infection and expanded surveillance Case definition for AIDS among adolescents and adults. MMWR Recomm Rep December 18, 1992/4KRR-17).
22. + T-Cell determinations with CD45 gating for persons infected with human immunodeficiency virus.2003/52(RR02);l-13.
23. World Health Organization. 2004. Scaling up anti-retroviral therapy in resource-limited settings: Treatment guidelines for a public health approach 2003 revision. Geneva: World Health Organization.
24. Getahun H, Harrington M, O'Brien R, Nunn P. 2007. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: Informing urgent policy changes. Lancet 369:2042-2049.
25. World Health Organization. 2006. The global plan to stop TB 2006-2015. Geneva: Stop TB Partnership.
26. World Health Organization. 2006. Diagnostics for Tuberculosis: Global Demand and Market Potential. World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases and the Foundation for Innovative New Diagnostics. Geneva: World Health Organization. http://www.stoptb.org/researchmovement/ assets/documents/tbdi.pdf.
27. Murray JF. 1998. Tuberculosis and HIV infection: Global perspectives. Respiration 65:335-342.
28. Aaron L, Saadoun D, Calatroni I, Memain N, Vincent V, Marchal G, Dupont B, Bouchaud O, Valeyre D, Lortholary O. 2004. Tuberculosis in HIV-infected patients: A comprehensive review. Clin Microbiol Infect 10:388-398.
29. World Health Organization. 2007. Global tuberculosis control- Surveillance, planning, financing. WHO report, Geneva.
30. World Health Organization and Stop TB Partnership. 2007. The Global MDR-TB and XDR-TB Response Plan 2007-2008. WHO Report, Geneva; WHO/HTM/TB/2007.387.
31. Dorman SE, Chaisson RE. 2007. From magic bullets back to the magic mountain: The rise of extensively drug-resistant tuberculosis. Nat Med 13:295-297.
32. Hudson CP, Wood R, Maartens G. 2000. Diagnosing HIV-associated tuberculosis: Reducing costs and diagnostic delay. Int J Tuberc Lung Dis 4:240-245.
33. Corporate Citizenship Company. 2006. Walking the talk: A Case Study of the BD Employee Volunteer Partnership Program in Zambia. London: Corporate Citizenship Company.
34. Blessing White, Inc. 2005. Employee engagement report. Princeton, NJ: Blessing White, Inc. p 2.